Literature DB >> 16402119

Pharmacology of intracellular signalling pathways.

Stefan R Nahorski1.   

Abstract

This article provides a brief and somewhat personalized review of the dramatic developments that have occurred over the last 45 years in our understanding of intracellular signalling pathways associated with G-protein-coupled receptor activation. Signalling via cyclic AMP, the phosphoinositides and Ca(2+) is emphasized and these systems have already been revealed as new pharmacological targets. The therapeutic benefits of most of such targets are, however, yet to be realized, but it is certain that the discipline of pharmacology needs to widen its boundaries to meet these challenges in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402119      PMCID: PMC1760751          DOI: 10.1038/sj.bjp.0706468

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

Review 1.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

2.  Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization.

Authors:  R A Challiss; I H Batty; S R Nahorski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

Review 3.  Neural and developmental actions of lithium: a unifying hypothesis.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

Review 4.  G proteins: transducers of receptor-generated signals.

Authors:  A G Gilman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 5.  Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.

Authors:  J R Atack; H B Broughton; S J Pollack
Journal:  Trends Neurosci       Date:  1995-08       Impact factor: 13.837

Review 6.  Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes.

Authors:  S R Nahorski; B V Potter
Journal:  Trends Pharmacol Sci       Date:  1989-04       Impact factor: 14.819

7.  Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors.

Authors:  S Jenkinson; S R Nahorski; R A Challiss
Journal:  Mol Pharmacol       Date:  1994-12       Impact factor: 4.436

Review 8.  Adenylyl cyclases and the interaction between calcium and cAMP signalling.

Authors:  D M Cooper; N Mons; J W Karpen
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

Review 9.  Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.

Authors:  S R Nahorski; C I Ragan; R A Challiss
Journal:  Trends Pharmacol Sci       Date:  1991-08       Impact factor: 14.819

Review 10.  New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor.

Authors:  R A Wilcox; W U Primrose; S R Nahorski; R A Challiss
Journal:  Trends Pharmacol Sci       Date:  1998-11       Impact factor: 14.819

View more
  1 in total

1.  Forskolin suppresses delayed-rectifier K+ currents and enhances spike frequency-dependent adaptation of sympathetic neurons.

Authors:  Luis I Angel-Chavez; Eduardo I Acosta-Gómez; Mario Morales-Avalos; Elena Castro; Humberto Cruzblanca
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.